Upadacitinib 68513-1043-09
- Manufacturer
- Abbvie Ireland Nl B.v.
- Dosage Form
- Tablet
- Product Type
- Drug For Further Processing
- Marketing Start
- November 11, 2022
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Upadacitinib | 45 mg/1 |
Selected Package
68513-1043-09Selected25000 TABLET in 1 DRUM (68513-1043-9)